SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-136200
Filing Date
2020-05-07
Accepted
2020-05-07 16:01:42
Documents
53
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d914940d10q.htm   iXBRL 10-Q 1418601
2 EX-31.1 d914940dex311.htm EX-31.1 6514
3 EX-31.2 d914940dex312.htm EX-31.2 6518
4 EX-32.1 d914940dex321.htm EX-32.1 5181
  Complete submission text file 0001193125-20-136200.txt   4845522

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ziop-20200331.xsd EX-101.SCH 40058
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20200331_cal.xml EX-101.CAL 24763
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20200331_def.xml EX-101.DEF 218299
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20200331_lab.xml EX-101.LAB 327374
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20200331_pre.xml EX-101.PRE 273867
18 EXTRACTED XBRL INSTANCE DOCUMENT d914940d10q_htm.xml XML 621211
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 20856174
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences